Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Viewray Inc (VRAY)

Viewray Inc (VRAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 457,150
  • Shares Outstanding, K 147,945
  • Annual Sales, $ 87,780 K
  • Annual Income, $ -120,200 K
  • 60-Month Beta 0.78
  • Price/Sales 5.22
  • Price/Cash Flow N/A
  • Price/Book 2.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.17
  • Number of Estimates 4
  • High Estimate -0.15
  • Low Estimate -0.19
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +19.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.53 +21.94%
on 08/28/20
3.15 -2.22%
on 08/19/20
-0.02 (-0.80%)
since 08/18/20
3-Month
1.94 +59.02%
on 06/26/20
3.61 -14.54%
on 08/11/20
+0.92 (+42.82%)
since 06/18/20
52-Week
1.11 +179.06%
on 03/16/20
4.88 -36.78%
on 12/03/19
-0.49 (-13.83%)
since 09/18/19

Most Recent Stories

More News
ViewRay® to Participate in Upcoming Investor Conferences

, /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in three upcoming virtual investor conferences.

VRAY : 3.10 (+0.32%)
10,000th Patient Receives Treatment with ViewRay's MRIdian System

, /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that 10,000 patients have been treated to date using the company's MRIdian MRI-Guided Radiation Therapy System, the world's first system...

VRAY : 3.10 (+0.32%)
ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer

, /PRNewswire/ --– ViewRay, Inc. (Nasdaq: VRAY) announced today that the GenesisCare Foundation's Compassionate Access Programme is now accepting patients for treatment on the MRIdian MRI-Guided Radiation...

VRAY : 3.10 (+0.32%)
Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac

, /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in has begun patient treatments with the MRIdian MRI-Guided Therapy System, a cutting-edge radiation therapy...

VRAY : 3.10 (+0.32%)
Kaohsiung Medical University Chung-Ho Memorial Hospital Begins Patient Treatments with ViewRay's MRIdian Linac

, /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, has begun patient treatments with the MRIdian MR-Guided...

VRAY : 3.10 (+0.32%)
ViewRay (VRAY) Reports Q2 Loss, Tops Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of -12.50% and 144.95%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

VRAY : 3.10 (+0.32%)
5 Top Momentum Stocks of June Amid Resurgence of Coronavirus

Despite market's roller-coaster ride, a handful of momentum stocks with a favorable Zacks Rank have provided double-digit returns so far in June.

MNTA : 52.36 (+0.06%)
CLW : 34.67 (+5.54%)
CMC : 22.05 (+1.75%)
VRAY : 3.10 (+0.32%)
DOMO : 37.53 (+0.62%)
ViewRay Announces 1-Year Outcomes on MR-Guided Radiation Treatment for Prostate Cancer Without Implanted Markers

, /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today the publication by the European Urology Oncology Journal of a prospective phase II study of MR-guided radiation therapy (MRgRT) in patients...

VRAY : 3.10 (+0.32%)
Top Ranked Momentum Stocks to Buy for June 23rd

Top Ranked Momentum Stocks to Buy for June 23rd

ZUO : 9.43 (+0.21%)
VRAY : 3.10 (+0.32%)
SNBR : 49.83 (+0.28%)
HEAR : 17.67 (+0.51%)
Tandem Diabetes (TNDM) Looks Good: Stock Adds 6.5% in Session

Tandem Diabetes (TNDM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

TNDM : 109.04 (+2.11%)
VRAY : 3.10 (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade VRAY with:

Business Summary

ViewRay Inc. is a medical device company. The company develops advanced radiation therapy technology for the treatment of cancer. MRIdian system provides continuous soft-tissue imaging during treatment. ViewRay Inc. is headquartered in Oakwood Village, Ohio.

See More

Key Turning Points

2nd Resistance Point 3.21
1st Resistance Point 3.15
Last Price 3.10
1st Support Level 3.00
2nd Support Level 2.91

See More

52-Week High 4.88
Fibonacci 61.8% 3.44
Last Price 3.10
Fibonacci 50% 2.99
Fibonacci 38.2% 2.55
52-Week Low 1.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar